Neurocrine Biosciences, Inc.
USD154.84
-6.16 (-3.83%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$160.40
Prev. Close
$161.00
Day Low
$154.19
Day High
$160.40
52W Low
$122.14
52W High
$162.39
Market Cap
$15.57B
Volume
1.02M
| 11,000 |
| $155.53 |
| 29 May 2026 | Onyia Jude | Chief Scientific Officer | M-Exempt | Disposed | 11,000 | $84.74 |
| 29 May 2026 | GORMAN KEVIN CHARLES | director | A-Award | Acquired | 5,248 | $155.83 |
| 29 May 2026 | POPS RICHARD F | director | A-Award | Acquired | 2,567 | $0.00 |
| 29 May 2026 | LYONS GARY A | director | A-Award | Acquired | 1,284 | $0.00 |
| 29 May 2026 | LYONS GARY A | director | A-Award | Acquired | 2,624 | $155.83 |
| 29 May 2026 | Mercier Johanna | director | A-Award | Acquired | 2,567 | $0.00 |
| 29 May 2026 | POON CHRISTINE A | director | A-Award | Acquired | 2,567 | $0.00 |
| 29 May 2026 | Sharp Shalini | director | A-Award | Acquired | 2,567 | $0.00 |
| 18 Sept 2024 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 22 Jun 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |